Sarcomatoid Renal Cell Carcinoma
Also known as: Renal cell carcinoma, sarcomatoid (morphologic abnormality) / Renal cell carcinoma with sarcomatoid features
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 1 | Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 | Recruiting | 1 |
DB06626 | Axitinib | 1 / 2 | Not Yet Recruiting | 1 |
DB00112 | Bevacizumab | 1 / 2 | Completed | 1 |
DB16680 | Cadonilimab | 1 / 2 | Not Yet Recruiting | 1 |
DB00398 | Sorafenib | 1 / 2 | Completed | 1 |
DB08875 | Cabozantinib | 2 | Active Not Recruiting | 1 |
DB08875 | Cabozantinib | 2 | Recruiting | 2 |
DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB06589 | Pazopanib | 2 | Active Not Recruiting | 1 |
DB01268 | Sunitinib | 2 | Active Not Recruiting | 1 |
DB08875 | Cabozantinib | 3 | Recruiting | 1 |
DB06186 | Ipilimumab | 3 | Recruiting | 1 |
DB09035 | Nivolumab | 3 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 3 | Recruiting | 1 |